Pediatrics
From the Journals
U.S. kids are taking melatonin for sleep, despite evidence gap
These findings should prompt clinicians to discuss with parents the various factors that could be driving sleep disturbances, and potential safety...
From the Journals
Long-term use of ADHD meds and CVD risk: New data
“Clinicians should be vigilant in monitoring signs and symptoms of cardiovascular diseases, particularly among those receiving higher doses.”
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
From the Journals
Childhood immunization schedule includes new RSV, mpox, meningococcal, and pneumococcal vaccines
Experts say the updates are timely and necessary, while noting that pediatricians should become familiar with the changes to discuss the topic...
Opinion
Fatal and nonfatal injuries
Recent pediatric fatality statistics reveal some troubling trends.
Latest News
Parent concerns a factor when treating eczema in children with darker skin types
For the parent, the pigmentation changes, rather than the inflammation, might be the governing issue and the reason that he or she brought the...
Latest News
Are we ready for systematic newborn genome sequencing?
In the future, DNA samples could be taken from babies for whole genome sequencing to look for diseases that are likely to crop up later in life....
Conference Coverage
Adolescents with migraine need smooth handoff to adult care
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Latest News
Already-available drug could help treat type 1 diabetes
DFMO inhibits the polyamine biosynthesis pathway, which plays a role in the inflammatory responses in autoimmune diseases.
From the Journals
Use the stool! Fecal microbiota transplants help kids with diarrheal infection
“When we think about the microbiome it makes sense to target kids, because they’re more apt to respond to these therapies. I worry that somebody...
Latest News
Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis
Lebrikizumab remains under review in the United States.